99m Tc-MIBI = 99m Tcmethoxyisobutylisonitrile ( 99m Tc-sestamibi); 99m Tc = technetium-99m; σ 1 , σ 2 = sigma receptors; CT = computed tomography; ER = estrogen receptor; FWHM = full width at half maximum; MIVE = 17α-[ 123 I]iodovinyl-11β-methoxyestradiol; MRI = magnetic resonance imaging; PEM = positron-emission mammography; PET = positron-emission tomography; PPV = positive predictive value; SMM = scintimammography; SPECT = single-photon-emission computed tomography.Available online http://breast-cancer-research.com/contents/7/4/153
AbstractAlthough mammography remains a key imaging method for the early detection and screening of breast cancer, the overall accuracy of this test remains low. Several radiopharmaceuticals have been proposed as adjunct imaging methods to characterize breast masses by single-photon-emission computed tomography (SPECT) and positron-emission tomography (PET). Useful in characterizing indeterminate palpable masses and in the detection of axillary metastases, these techniques are insufficiently sensitive to detect subcentimetric tumor deposits. Their role in staging nodal involvement of the axillary areas therefore currently remains limited. Several enzymes and receptors have been targeted for imaging breast cancers with PET. [ 18 F]Fluorodeoxyglucose is particularly useful in the detection and staging of recurrent breast cancer and in assessing the response to chemotherapy. Several other ligands targeting proliferative activity, protein synthesis, and hormone and cell-membrane receptors may complement this approach by providing unique information about biological characteristics of breast cancer across primary and metastatic tumor sites.
IntroductionEarly diagnosis remains the best method of improving the odds of curing breast cancer. Among the tools currently widely available, screening mammography has been credited with an earlier diagnosis and a decreased risk of death from breast cancer. However, false negatives occur frequently, particularly when imaging post-surgical recurrence, fibrocystic breast disease and dense breast tissue in younger women [1]. Mammography also has a low positive predictive value, and accurate second-line imaging methods are useful in some instances to reduce the number of unnecessary excisional biopsies.The presence of lymph node spread is determined by axillary dissection, a diagnostic surgical procedure that can significantly impair the quality of life of many women. The less invasive sentinel node biopsy may not always detect axillary involvement because the sentinel nodes can be bypassed in 3 to 7% of cases [2][3][4][5]. Nodal metastases can also occur in internal mammary or mediastinal nodal groups, which are usually not sampled in conventional surgical staging. Multiple imaging studies are often prescribed to exclude the presence of bone, liver and lung metastases.Despite some progress arising from increased public awareness and screening programs that have tended to improve the stage at which breast cancers are detected, the rate of recurrence rema...